While ENDO is always the major in-person event that brings the whole endocrine community together, with this being epitomized at ENDO 2024, the Society is hard at work preparing an impressive slate of meetings this fall.
In September, members can look forward to our ever-popular Endocrine Board Review (EBR) and Clinical Endocrinology Update (CEU), both of which will be held virtually. Following these are two entirely new meetings: an in-person conference on steroid hormones and receptors (October 15-18), and a virtual summit on the use of artificial intelligence (AI) in healthcare (November 8-9).
While we all recognize the hurdles, expense and carbon impact of traveling to meetings across the globe, we also all recognize the value of meeting our colleagues face to face, and the networking opportunities and rich exchanges that can only arise from that format.
I’m proud to be part of an organization that never rests to provide our members with the best educational experiences possible. Below are some details on these events.
EBR 2024, September 6-8, is an online learning program for fellows, practicing endocrinologists, and other healthcare professionals preparing for the American Board of Internal Medicine’s (ABIM), Endocrinology, Diabetes, and Metabolism Certification Exam. Led by experts in each topical area, participants are guided through the intensive program using the Endocrine Board Review 16th Edition (2024) with 220 clinical case questions based on the previous year’s exam content. Topics include case studies affecting adrenal, bone and calcium, diabetes, female reproduction, lipids and obesity, male reproduction, and pituitary.
The program is so effective that the Society guarantees a passing score, or participants receive free registration for EBR 2025!
CEU 2024, September 19-21, provides cutting-edge knowledge for clinicians on how to treat endocrine conditions using the latest clinical guidelines and breakthrough therapies. The first day includes topics such as diabetes prevention, growth hormone replacement updates, and vertebral fragility fracture management. Day two delves into safe exercise strategies for diabetes patients, hyperthyroidism, and the role of genetics in obesity. Day three discusses osteoporosis management, nutrition integration into healthcare, and treatments for erectile dysfunction.
CEU 2024’s six hours of content across 36 sessions is certified for 27 AMA PRA Category 1 Credits™ and 6.75 ABIM MOC Points. Recordings will be available online within 72 hours after the meeting.
Society Launches Two New Meetings
In addition to these events, the Society is excited to offer two new meetings of interest to our research members and those who want to learn more about AI in healthcare.
The 1st International Conference on Steroid Hormones and Receptors (SHR 2024), October 15-18, 2024, takes place at the University of New Mexico Comprehensive Cancer Center, in Albuquerque, N.M. The meeting is designed to explore advances in steroid hormone and receptor functions, both rapid and genomic, in various aspects of biology and medicine, and in both normal physiology and pathophysiology. Attendees will include leading scientists, researchers, physicians, post-doctoral trainees, and students working in various disciplines of steroid hormone and receptor biology and medicine. (Learn more at: www.endocrine.org/meetings-and-events/shr-2024.)
The Artificial Intelligence (AI) in Healthcare Virtual Summit, November 8-9, is designed for healthcare providers, professionals, researchers, technologists, industry stakeholders, and educators. The summit will explore the potential of AI to revolutionize patient care and shape the future of medicine. (Learn more at: www.endocrine.org/meetings-and-events/ai-summit.)
Online Learning vs. In-person Learning
We have been asked what drives the format of Society meetings.
As in recent years, EBR 2024 and CEU 2024 once again will take place entirely online. The same holds true for the AI Virtual Summit. For meetings of this type with focused learning, the format offers several distinct advantages, and even following the end of pandemic-era restrictions, many of us have grown accustomed to virtual education.
Virtual meetings allow for many more colleagues from around the world to participate, accepting that for some the time difference of some sessions may be inconvenient. For example, CEU 2023 drew nearly 1,070 attendees from more than 30 countries. By contrast, our last in-person CEU meeting, held in 2019 in Miami, Fla., and Seattle, Wash., drew several hundred participants in total. Similar attendance spikes were seen for the more U.S.-focused EBR after it went virtual.
I’m proud to be part of an organization that never rests to provide our members with the best educational experiences possible.
In contrast, whilst we all recognize the hurdles, expense and carbon impact of traveling to meetings across the globe, we also all recognize the value of meeting our colleagues face to face, and the networking opportunities and rich exchanges that can only arise from that format. It is for these reasons that our meeting on steroid hormones and receptors will be in person, as will ENDO 2025 in San Francisco next July.
So, whether virtually or in-person, I look forward to connecting this fall with many of my fabulous colleagues from across the table or across world.
John Newell-Price, MD, PhD, FRCP
Endocrine Society President